SCHEMBL3353921

SCHEMBL3353921

O=C(O)CCC1CCCC1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA4 P22748 1/20 0.48
PTGS1 P23219 11/20 0.39
PTGS2 P35354 10/20 0.39
MT-CO1 P00395 1/20 0.39
MT-CO2 P00403 1/20 0.39
FOLH1 Q04609 1/20 0.38
LMNA P02545 3/20 0.35
HSD17B10 Q99714 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP2C9 P11712 1/20 0.35
MEN1 O00255 1/20 0.35
NR1I2 O75469 1/20 0.35
POLB P06746 1/20 0.35
THRB P10828 1/20 0.35
TSHR P16473 1/20 0.35
ACHE P22303 1/20 0.35
APEX1 P27695 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2495787 0.96 CA1 (0.54) CA1CA2CA4PTGS1PTGS2
SCHEMBL27578464 0.88 ALOX5 (0.46) CA1CA2CA4PTGS1PTGS2
SCHEMBL3346216 0.86 LMNA (0.37) CA1CA2CA4FOLH1LMNA
SCHEMBL4802734 0.83 CA1 (0.50) CA1CA2CA4LMNAHSD17B10
SCHEMBL8158503 0.81 ALDH1A1 (0.43) FOLH1LMNAHSD17B10ALDH1A1CYP2C9
SCHEMBL16230526 0.80 ALOX5 (0.47) CA1CA2CA4LMNAHSD17B10
SCHEMBL9294224 0.77 SLC6A12 (0.44) CA1CA2CA4PTGS1PTGS2
SCHEMBL4120941 0.77 SLC6A12 (0.44) CA1CA2CA4PTGS1PTGS2
SCHEMBL4120948 0.77 SLC6A12 (0.44) CA1CA2CA4PTGS1PTGS2
SCHEMBL15616801 0.77 SLC6A12 (0.44) CA1CA2CA4PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8883720-B2 Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity POLYPHOR AG (CH) 2014-11-11 US disclosed
US-20110312879-A1 TEMPLATE-FIXED BETA-HAIRPIN PEPTIDOMIMETICS WITH CXCR4 ANTAGONIZING ACTIVITY POLYPHOR AG (CH) 2011-12-22 US disclosed
WO-2010060479-A1 TEMPLATE-FIXED BETA-HAIRPIN PEPTIDOMIMETICS WITH CXCR4 ANTAGONIZING ACTIVITY POLYPHOR AG (CH) 2010-06-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312879-A1 TEMPLATE-FIXED BETA-HAIRPIN PEPTIDOMIMETICS WITH CXCR4 ANTAGONIZING ACTIVITY CXCL12, CXCR4, CXCR1 CA1 2295/4885CA2 3497/4885CA4 3153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.